Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma

被引：79

作者：

Leng, Xue-Feng ^{[1
]}

Daiko, Hiroyuki ^{[2
]}

Han, Yong-Tao ^{[1
]}

Mao, You-Sheng ^{[3
]}

机构：

[1] Univ Elect Sci & Technol China UESTC, Sichuan Canc Hosp & Res Inst, Sch Med, Div Thorac Surg, 55,Sect 4,South Renmin Rd, Chengdu 610041, Peoples R China

[2] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan

[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Thorac Surg, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China

来源：

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 2020年 / 1482卷 / 01期

关键词：

esophageal squamous cell carcinoma; multidisciplinary treatment; neoadjuvant chemoradiotherapy; neoadjuvant chemotherapy; neoadjuvant immunotherapy; LYMPH-NODE DISSECTION; PHASE-III TRIAL; MINIMALLY INVASIVE ESOPHAGECTOMY; PATHOLOGICAL COMPLETE RESPONSE; PERIOPERATIVE CHEMOTHERAPY; EXPERT CONSENSUS; OPEN-LABEL; CANCER; CHEMORADIOTHERAPY; SURVIVAL;

D O I：

10.1111/nyas.14508

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide, especially in East Asia. ESCC accounts for more than 90% of esophageal cancer. Currently, neoadjuvant therapy in combination with surgical resection is the mainstay of treatment. However, the overall survival rate of patients with locally advanced ESCC is not satisfactory even when treated following the standard treatment guidelines. With neoadjuvant chemoradiotherapy, chemotherapy, or emerging immunotherapy, continuous exploration of efficacy in relation to ESCC is expected to improve overall survival further. Here, we review and summarize current evidence for efficacy of preoperative therapy for locally advanced ESCC.

引用

页码：213 / 224

页数：12

共 59 条

[1] RADICAL LYMPH-NODE DISSECTION FOR CANCER OF THE THORACIC ESOPHAGUS [J].

AKIYAMA, H ;

TSURUMARU, M ;

UDAGAWA, H ;

KAJIYAMA, Y .

ANNALS OF SURGERY, 1994, 220 (03) :364-373

[2] Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Hofheinz, Ralf D. ;

Pauligk, Claudia ;

Kopp, Hans-Georg ;

Haag, Georg Martin ;

Luley, Kim Barbara ;

Meiler, Johannes ;

Homann, Nils ;

Lorenzen, Sylvie ;

Schmalenberg, Harald ;

Probst, Stephan ;

Koenigsmann, Michael ;

Egger, Matthias ;

Prasnikar, Nicole ;

Caca, Karel ;

Trojan, Joerg ;

Martens, Uwe M. ;

Block, Andreas ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Clemens, Michael ;

Illerhaus, Gerald ;

Zirlik, Katja ;

Behringer, Dirk M. ;

Schmiegel, Wolff ;

Pohl, Michael ;

Heike, Michael ;

Ronellenfitsch, Ulrich ;

Schuler, Martin ;

Bechstein, Wolf O. ;

Koenigsrainer, Alfred ;

Gaiser, Timo ;

Schirmacher, Peter ;

Hozaeel, Wael ;

Reichart, Alexander ;

Goetze, Thorsten O. ;

Sievert, Mark ;

Jaeger, Elke ;

Moenig, Stefan ;

Tannapfel, Andrea .

LANCET ONCOLOGY, 2016, 17 (12) :1697-1708

[3] Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204 [J].

Ando, N ;

Iizuka, T ;

Ide, H ;

Ishida, K ;

Shinoda, M ;

Nishimaki, T ;

Takiyama, W ;

Watanabe, H ;

Isono, K ;

Aoyama, N ;

Makuuchi, H ;

Tanaka, O ;

Yamana, H ;

Ikeuchi, S ;

Kabuto, T ;

Nagai, K ;

Shimoda, Y ;

Kinjo, Y .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4592-4596

[4] A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) [J].

Ando, Nobutoshi ;

Kato, Hoichi ;

Igaki, Hiroyasu ;

Shinoda, Masayuki ;

Ozawa, Soji ;

Shimizu, Hideaki ;

Nakamura, Tsutomu ;

Yabusaki, Hiroshi ;

Aoyama, Norio ;

Kurita, Akira ;

Ikeda, Kenichiro ;

Kanda, Tatsuo ;

Tsujinaka, Toshimasa ;

Nakamura, Kenichi ;

Fukuda, Haruhiko .

ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) :68-74

[5] Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 [J].

不详 .

CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (02) :223-258

[6] Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study [J].

Borggreve, A. S. ;

Mook, S. ;

Verheij, M. ;

Mul, V. E. M. ;

Bergman, J. J. ;

Bartels-Rutten, A. ;

ter Beek, L. C. ;

Beets-Tan, R. G. H. ;

Bennink, R. J. ;

Henegouwen, M. I. van Berge ;

Brosens, L. A. A. ;

Defize, I. L. ;

van Dieren, J. M. ;

Dijkstra, H. ;

van Hillegersberg, R. ;

Hulshof, M. C. ;

van Laarhoven, H. W. M. ;

Lam, M. G. E. H. ;

van Lier, A. L. H. M. W. ;

Muijs, C. T. ;

Nagengast, W. B. ;

Nederveen, A. J. ;

Noordzij, W. ;

Plukker, J. T. M. ;

van Rossum, P. S. N. ;

Ruurda, J. P. ;

van Sandick, J. W. ;

Weusten, B. L. A. M. ;

Voncken, F. E. M. ;

Yakar, D. ;

Meijer, G. J. .

BMC CANCER, 2018, 18

[7] Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study [J].

Borggreve, Alicia S. ;

Goense, Lucas ;

van Rossum, Peter S. N. ;

Heethuis, Sophie E. ;

van Hillegersberg, Richard ;

Lagendijk, Jan J. W. ;

Lam, Marnix G. E. H. ;

van Lier, Astrid L. H. M. W. ;

Mook, Stella ;

Ruurda, Jelle P. ;

van Vulpen, Marco ;

Voncken, Francine E. M. ;

Aleman, Berthe M. P. ;

Bartels-Rutten, Annemarieke ;

Ma, Jingfei ;

Fang, Penny ;

Musall, Benjamin C. ;

Lin, Steven H. ;

Meijer, Gert J. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05) :998-1009

[8] Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis [J].

Chan, Kelvin K. W. ;

Saluja, Ronak ;

Delos Santos, Keemo ;

Lien, Kelly ;

Shah, Keya ;

Cramarossa, Gemma ;

Zhu, Xiaofu ;

Wong, Rebecca K. S. .

INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (02) :430-437

[9] Factors associated with survival in patients with oesophageal cancer who achieve pathological complete response after chemoradiotherapy: a nationwide population-based study [J].

Chao, Yin-Kai ;

Chen, Hui-Shan ;

Wang, Bing-Yen ;

Hsu, Po-Kuei ;

Liu, Chia-Chuan ;

Wu, Shiao-Chi .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 51 (01) :155-159

[10] Pretreatment T3-4 Stage is an Adverse Prognostic Factor in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response Following Preoperative Chemoradiotherapy [J].

Chao, Yin-Kai ;

Chan, Sheng-Chieh ;

Liu, Yun-Hen ;

Chen, Huan-Wu ;

Wan, Yung-Liang ;

Chang, Hsien-Kun ;

Fan, Kang-Hsing ;

Liu, Hui-Ping .

ANNALS OF SURGERY, 2009, 249 (03) :392-396

← 1 2 3 4 5 6 →